LUCRIN

This brand name is authorized in Australia, Israel, Mexico, Netherlands, New Zealand, Poland, Singapore, Turkey, South Africa

Active ingredients

The drug LUCRIN contains one active pharmaceutical ingredient (API):

1 Leuprorelin UNII 37JNS02E7V - LEUPROLIDE ACETATE

Leuprorelin is inactive when given orally due to poor membrane permeability and an almost complete inactivation by intestinal proteolytic enzymes. Leuprorelin has potent LHRH agonist properties when given during short-term and intermittent therapy, however, when administered in a continuous, nonpulsatile manner, LHRH analogs induce inhibition of gonadotropin secretion and suppression of testicular steroidogenesis. Read about Leuprorelin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUCRIN Depot Solution for injection	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02AE02	Leuprorelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11943N, 11944P, 11960L, 8875D, 8876E, 8877F
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3483, 4101
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 443M89, 468M90
Country: NL	Z-Index G-Standaard	Identifier(s): 13295292
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 64815, 76589, 76597, 89214
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12227, 12246
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100039890, 100247418
Country: SG	Health Sciences Authority	Identifier(s): 05265P, 08862P, 10742P, 14004P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680656080117, 8680656080124, 8680656080131, 8680656080148, 8680656080155
Country: ZA	Health Products Regulatory Authority	Identifier(s): S/21.10/51